发明名称 PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
摘要 A pharmaceutical composition containing, as the active ingredient, 4-{[(1R,2s,3S,5s,7s)-5-hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-b]pyridine-5-carboxamide, of which the solubility in an acidic pH region is different from that in a neutral pH region, with rapid disintegration property and rapid drug dissolution property as well as the expectation of a good drug dosing compliance, is provided. The pharmaceutical composition for oral administration of the present invention contains 4-{[(1R,2s,3S,5s,7s)-5-hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-b]pyridine-5-carboxamide or a pharmaceutically acceptable salt thereof, and a hydrophilic lubricant, and is useful as a pharmaceutical composition for oral administration with rapid disintegration property and rapid drug dissolution property as well as the expectation of a good drug dosing compliance.
申请公布号 EP2979698(A4) 申请公布日期 2016.11.16
申请号 EP20140774086 申请日期 2014.03.28
申请人 ASTELLAS PHARMA INC. 发明人 TAKAE SEIJI;KOJIMA HIROYUKI;SAKURAI ATSUSHI;TAMURA TETSUYA;TASAKI HIROAKI;MURO ATSUSHI
分类号 A61K31/437;A61K9/20;A61K9/30;A61P29/00;A61P37/02;A61P37/08;A61P43/00 主分类号 A61K31/437
代理机构 代理人
主权项
地址